There’s no good clinical facts on a defined withdrawal syndrome from BPC-157, largely simply because there’s no reliable medical facts on A great deal of something with this peptide in people. That absence of evidence isn’t similar to an absence of possibility. If BPC-157 does meaningfully interact with dopamine signaling the best way animal